Split History
ETFs Holding AVEO »    AVEO Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AVEO Pharmaceuticals is a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines for patients with cancer. Co.'s product candidates include: Tivozanib, which is for the treatment of renal cell carcinoma, hepatocellular carcinoma, immunologically cold tumors and cholangiocarcinoma; Ficlatuzumab, which is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor; AV-380, which is a humanized IgG1 monoclonal antibody that targets growth differentiation factor 15; AV-203, which is a humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353, which is a IgG1 monoclonal antibody that targets the Notch 3 pathway. According to our AVEO split history records, AVEO has had 1 split.
AVEO split history picture
AVEO (AVEO) has 1 split in our AVEO split history database. The split for AVEO took place on February 20, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of AVEO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as AVEO conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the AVEO split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AVEO shares, starting with a $10,000 purchase of AVEO, presented on a split-history-adjusted basis factoring in the complete AVEO split history. AVEO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 01/19/2023
Start price/share: $14.10
End price/share: $15.00
Dividends collected/share: $0.00
Total return: 6.38%
Average Annual Total Return: 0.71%
Starting investment: $10,000.00
Ending investment: $10,638.67
Years: 8.75
Date Ratio
02/20/20201 for 10
AVEO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AVGR Split History
AVXL Split History
AXDX Split History
AYTU Split History
AZN Split History
AZRX Split History
BAX Split History
BCR Split History
BDMS Split History
BDX Split History

Also explore: AVEO shares outstanding history

Email EnvelopeFree AVEO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Smart for Life, Inc. (SMFL)
Windtree Therapeutics, Inc. (WINT)
Golden Sun Health Technology Group Limited (GSUN)
Zapp Electric Vehicles Group Limited (ZAPP)
Beneficient (BENF)
MySize, Inc. (MYSZ)
Gorilla Technology Group Inc. (GRRR)
Sunshine Biopharma, Inc. (SBFM)
NFT Ltd. (MI)
WiSA Technologies, Inc. (WISA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AVEO Insider Buying

AVEO Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.